Crinetics Pharmaceuticals Inc (CRNX)

Finanzdaten der Crinetics Pharmaceuticals Inc-Aktie (CRNX)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	100.00% -	0.346	0.988	2.679	0.709
Operating Expenses	5.62% 62.66	59.32	53.98	50.66	48.27
Benefits Costs and Expenses	218.54	-	-	-	168.66
Costs And Expenses	8.00% 54.58	59.32	53.98	50.66	44.30
Depreciation and Amortization	4.03% 0.262	0.273	0.28	0.283	0.28
Operating Income/Loss	6.24% -62.66	-58.98	-52.99	-47.98	-47.56
Nonoperating Income/Loss	168.76% 6.762	2.516	2.016	1.983	2.565
Income/Loss From Continuing Operations Before Tax	63,262% -218.54	0.346	0.988	2.679	-167.95
Income/Loss From Continuing Operations After Tax	4.59% -60.10	-57.46	-50.98	-45.99	-44.99
Net Income/Loss	4.59% -60.10	-57.46	-50.98	-45.99	-44.99
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	94.60% 3.068	56.81	54.27	53.91	0.626
Diluted Average Shares	94.60% 3.068	56.81	54.27	53.91	0.626
Basic Earnings Per Share	12.87% -0.88	-1.01	-0.94	-0.85	-0.83
Diluted Earnings Per Share	12.87% -0.88	-1.01	-0.94	-0.85	-0.83
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-